Skip to Content
Merck
CN
All Photos(1)

Key Documents

View All Documentation

Safety Information

Y0000851

Doxepin for system suitability

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

Doxepin hydrochloride, 11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepine hydrochloride

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C19H21NO · HCl
CAS Number:
1229-29-4
Molecular Weight:
315.84
MDL number:
MFCD00079135
UNSPSC Code:
41116107
PubChem Substance ID:
329831189
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

doxepin

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

Cl[H].CN(C)CC\C=C1/c2ccccc2COc3ccccc13

InChI

1S/C19H21NO.ClH/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19;/h3-6,8-12H,7,13-14H2,1-2H3;1H/b17-11+;

InChI key

MHNSPTUQQIYJOT-SJDTYFKWSA-N

Looking for similar products? Visit Product Comparison Guide

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Doxepin for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

related product

Product No.
Description
Pricing

Y0000838

Doxepin hydrochloride, European Pharmacopoeia (EP) Reference Standard

1225511

Doxepin Related Compound A, United States Pharmacopeia (USP) Reference Standard

1225500

Doxepin hydrochloride, United States Pharmacopeia (USP) Reference Standard

1225522

Doxepin Related Compound B, United States Pharmacopeia (USP) Reference Standard

1225533

Doxepin Related Compound C, United States Pharmacopeia (USP) Reference Standard

BP136

Doxepin hydrochloride, British Pharmacopoeia (BP) Reference Standard

BP823

Doxepin impurity standard, British Pharmacopoeia (BP) Reference Standard

PHR8923

Doxepin Related Compound C

PHR8924

Doxepin Related Compound B, Pharmaceutical Secondary Standard; Certified Reference Material

Pictograms

Skull and crossbones
GHS06

Signal Word

Danger

Hazard Statements

H301

Precautionary Statements

P301 + P330 + P331 + P310

Hazard Classifications

Acute Tox. 3 Oral

Storage Class Code

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Information

监管及禁止进口产品

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

James L Zazzali et al.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 108(2), 98-102 (2012-02-01)
The literature on chronic idiopathic urticaria (CIU) lacks large-scale population-based studies. To characterize an insured population with CIU, including their demographic characteristics and comorbidities. We conducted a cross-sectional analysis using insurance claims. We included patients with 1 outpatient claim with
Donald R Lynch et al.
Cardiology journal, 19(4), 434-438 (2012-07-25)
Vorinostat is a histone deacetylase inhibitor used in the treatment of recurrent or persistent cases of cutaneous T-cell lymphoma (CTCL). A retrospective review of 116 patients from phase I and II clinical trials who had a baseline and at least
Xueqing Hu et al.
Neurochemistry international, 61(2), 207-218 (2012-05-09)
5-HT receptor changes remain controversial in posttraumatic stress disorder (PTSD) models. This study looks at the relationship between traumatic injuries and the alterations in 5-HT(2A) and 5-HT(2C) receptors in the goldfish brain. The effect of treatment with doxepin and fluoxetine
James A Tarbox et al.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 107(3), 239-243 (2011-08-31)
Laboratory tests are routinely ordered to identify or rule out a cause in patients with chronic urticaria/angioedema (CUA). The results of these tests are usually within normal limits or unremarkable. To investigate the proportion of abnormal test results in patients
Alan Lankford et al.
Sleep medicine, 13(2), 133-138 (2011-12-27)
The efficacy and safety of doxepin (DXP), a histamine H(1) receptor antagonist, was evaluated in elderly adults with sleep maintenance insomnia. This was a randomized, double-blind, placebo-controlled outpatient trial. Elderly adults meeting DSM-IV-TR criteria for primary insomnia were randomized to
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service